Author

Pierre Hodara

Inserm

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Organism:human· 1 Approach:machine learning (classical)· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Adrien SixiD· 1 shared Alexandra Roux· 1 shared Alice CourtiesiD· 1 shared Caroline Aheng· 1 shared Claire Ribet· 1 shared David KlatzmanniD· 1 shared Encarnita Mariotti‐FerrandiziD· 1 shared Éric VicautiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Adrien SixORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A regulatory T cell signature provides a shared molecular basis for the therapeutic window of opportunity in rheumatic disease

Marie Binvignat, Federica Martina, Fabien Pitoiset, Alexandra Roux, Roberta Lorenzon, Pierre Hodara, Pierre Barennes, Hélène Vantomme, Michèle Sastre, Signe Hässler, Claire Ribet, Alice Courties, Vanessa Mhanna, Paul Stys, Leslie Adda, , Encarnita Mariotti‐Ferrandiz

The paper identifies a shared Treg dysfunction signature across rheumatic diseases, suggesting a therapeutic window of opportunity for Treg-targeted treatments.

bioRxiv · Sep 27, 2026 · PreprintImmunology